NeuroSearch and GSK in Depression Deal

By Business Review Editor

Pharma Deals Review: Vol 2003 Issue 32 (Table of Contents)

Published: 3 Jan-2003

DOI: 10.3833/pdr.v2003.i32.954     ISSN: 1756-7874

Section: General

Abstract

NeuroSearch entered into a deal with GlaxoSmithKline (GSK) that provided GSK an option on compounds arising from NeuroSearch’s research into the use of triple action monoamine reuptake inhibitors to treat depression...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details